Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage

NCT05836831 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3400

Last updated 2026-01-22

No results posted yet for this study

Summary

This multicenter, pragmatic randomized, open-label clinical trial aims to assess whether Tranexamic Acid improves outcomes in adult patients with spontaneous intracerebral haemorrhage.

The participants presenting within 4.5 hours of the onset of symptoms of stroke with intracerebral haemorrhage confirmed on Computed Tomography (CT Scan) will be randomized into two groups in a 1:1 ratio using a central online randomization. The treatment arm will consist of giving intravenously 2 grams of Tranexamic Acid in 100 ml 0.9% sodium chloride administered over 45 minutes. Control arm patients will receive standard of care treatment as per the institutional protocol. In both arms, intensive systolic blood pressure reduction to less than 140 mmHg will be done using antihypertensive medications, which has to be achieved within one hour and will be maintained over next seven days. The choice of antihypertensive drug will depend on the clinician's preference.

Both groups will have a repeat CT scan after 24 hours to check for any increase in the haematoma volume. Any deterioration in the neurological status will warrant urgent brain imaging. On day 7, the patient will be assessed for their NIHSS score and mRS score. On day 90, quality of life and the functional outcome will be assessed.

Conditions

  • Intracerebral Hemorrhagic Stroke

Interventions

DRUG

Tranexamic acid injection

The treatment arm will consist of giving intravenously 2 grams of Tranexamic Acid in 100 ml sodium chloride 0.9 % administered over 45 minutes.

Sponsors & Collaborators

  • Indian Council of Medical Research

    collaborator OTHER_GOV
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology

    collaborator OTHER_GOV
  • Post Graduate Institute of Medical Education and Research, Chandigarh

    collaborator OTHER
  • St. Stephen's Hospital, Delhi

    collaborator OTHER
  • All India Institute of Medical Sciences

    collaborator OTHER
  • Amrita Institute of Medical Sciences & Research Center

    collaborator OTHER
  • Kasturba Medical College Manipal, India

    collaborator UNKNOWN
  • Institute of Neurosciences Kolkata

    collaborator OTHER
  • Bangur Institute of Neurosciences Kolkata, India

    collaborator UNKNOWN
  • Guwahati Neurological Research Center, Guwahati, India

    collaborator UNKNOWN
  • Baptist Christian Hospital, Tezpur, India

    collaborator UNKNOWN
  • National Institute of Mental Health and Neuro Sciences, India

    collaborator OTHER
  • Jawaharlal Institute of Postgraduate Medical Education & Research

    collaborator OTHER_GOV
  • Christian Medical College, Vellore, India

    collaborator OTHER
  • CARE Hospitals Hyderabad, India

    collaborator UNKNOWN
  • Lalitha Super Specialities Hospital Guntur, India

    collaborator UNKNOWN
  • Dr. Ramesh Cardiac and Multispeciality Hospital Guntur, India

    collaborator UNKNOWN
  • Government General Hospital Guntur, India

    collaborator UNKNOWN
  • Fortis Escorts Hospital Jaipur, India

    collaborator UNKNOWN
  • Institute of Medical Sciences of the Banaras Hindu University, India

    collaborator OTHER
  • Atal Institute of Medical Super Specilities, (AIMSS) Chamiana, Shimla

    collaborator UNKNOWN
  • All India Institute of Medical Sciences, Bhubaneswar

    collaborator OTHER
  • KLEs Dr. Prabhakar Kore Hospital & Medical Research Centre Balgaum, India

    collaborator UNKNOWN
  • Guru Gobind Singh Medical College & Hospital

    collaborator OTHER
  • PBM Hospital Bikaner, India

    collaborator UNKNOWN
  • Shree Krishna Hospital Pramukhswami Medical College Anand, India

    collaborator UNKNOWN
  • Apollo Excelcare Hospitals Guwahati, India

    collaborator UNKNOWN
  • Manipal Hospital Bangalore, India

    collaborator UNKNOWN
  • Artemis Hospital Gurgaon, India

    collaborator UNKNOWN
  • Dr. Kamakshi Memorial Hospital Chennai, India

    collaborator UNKNOWN
  • Bharati Vidyapeeth DTU Medical College Pune, India

    collaborator UNKNOWN
  • Aster MIMS Hospital Calicut, India

    collaborator UNKNOWN
  • Holy Spirit Hospital Mumbai, India

    collaborator UNKNOWN
  • Sparsh Superspeciality Hospital Bangalore, India

    collaborator UNKNOWN
  • King George's Medical University, Lucknow, India

    collaborator UNKNOWN
  • Assam Medical College, Dibrugarh, India

    collaborator UNKNOWN
  • KG Hospital and Post Graduate Medical Institute Coimbatore, India

    collaborator UNKNOWN
  • Tirunelveli Medical College, Tirunelveli, India

    collaborator UNKNOWN
  • Santokba Durlabhji Memorial Hospital, Jaipur, India

    collaborator UNKNOWN
  • Tezpur Medical College and Hospital, Assam, India

    collaborator UNKNOWN
  • Baby Memorial Hospital Calicut, India

    collaborator UNKNOWN
  • Institute of Human Behaviour and Allied Sciences Delhi, India

    collaborator UNKNOWN
  • The Calcutta Medical Research Institute, Kolkata, India

    collaborator UNKNOWN
  • Fortis Hospital Mulund Mumbai, India

    collaborator UNKNOWN
  • Government Medical College Trivandrum, India

    collaborator UNKNOWN
  • Ruby Hall Clinic, Pune, India

    collaborator UNKNOWN
  • Manipal Hospital Goa, India

    collaborator UNKNOWN
  • Christian Medical College and Hospital, Ludhiana, India

    lead OTHER

Principal Investigators

  • Jeyaraj D Pandian, MD DM · Christian Medical College and Hospital, Ludhiana, Punjab, India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05836831 on ClinicalTrials.gov